Evidence map›Paper›PMID 37200077›Full record

ArticleJMIR cancer2023

A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study.

Khalil Hodroj, David Pellegrin, Cindy Menard, Thomas Bachelot, Thierry Durand, Philippe Toussaint, Armelle Dufresne, Benoite Mery, Olivier Tredan, Thibaut Goulvent and 1 more

Abstract read
In one paragraph

Article in JMIR cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Khalil HodrojCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0002-6629-2662
David PellegrinRoche Healthcare Development Division - Roche Diagnostics France, Meylan, Meylan, France.ORCID https://orcid.org/0009-0000-1902-9119
Cindy MenardCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0003-4356-5215
Thomas BachelotCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0002-0866-9484
Thierry DurandCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0003-3861-8394
Philippe ToussaintCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0003-2839-1579
Armelle DufresneCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0002-6637-3526
Benoite MeryCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0002-6788-634X
Olivier TredanCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0001-5881-9383
Thibaut GoulventRoche Healthcare Development Division - Roche Diagnostics France, Meylan, Meylan, France.ORCID https://orcid.org/0000-0003-2607-7754
Pierre HeudelCentre Leon Berard, Lyon, France.ORCID https://orcid.org/0000-0002-2155-549X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer treatment is constantly evolving toward a more personalized approach based on clinical features, imaging, and genomic pathology information. To ensure the best care for patients, multidisciplinary teams (MDTs) meet regularly to review cases. Notwithstanding, the conduction of MDT meetings is challenged by medical time restrictions, the unavailability of critical MDT members, and the additional administrative work required. These issues may result in members missing information during MDT meetings and postponed treatment. To explore and facilitate improved approaches for MDT meetings in France, using advanced breast cancers (ABCs) as a model, Centre Léon Bérard (CLB) and ROCHE Diagnostics cocreated an MDT application prototype based on structured data.

objectiveIn this paper, we want to describe how an application prototype was implemented for ABC MDT meetings at CLB to support clinical decisions.

methodsPrior to the initiation of cocreation activities, an organizational audit of ABC MDT meetings identified the following four key phases for the MDT: the instigation, preparation, execution, and follow-up phases. For each phase, challenges and opportunities were identified that informed the new cocreation activities. The MDT application prototype became software that integrated structured data from medical files for the visualization of the neoplastic history of a patient. The digital solution was assessed via a before-and-after audit and a survey questionnaire that was administered to health care professionals involved in the MDT.

resultsThe ABC MDT meeting audit was carried out during 3 MDT meetings, including 70 discussions of clinical cases before and 58 such discussions after the implementation of the MDT application prototype. We identified 33 pain points related to the preparation, execution, and follow-up phases. No issues were identified related to the instigation phase. Difficulties were grouped as follows: process challenges (n=18), technological limitations (n=9), and the lack of available resources (n=6). The preparation of MDT meetings was the phase in which the most issues (n=16) were seen. A repeat audit, which was undertaken after the implementation of the MDT application, demonstrated that (1) the discussion times per case remained comparable (2 min and 22 s vs 2 min and 14 s), (2) the capture of MDT decisions improved (all cases included a therapeutic proposal), (3) there was no postponement of treatment decisions, and (4) the mean confidence of medical oncologists in decision-making increased.

conclusionsThe introduction of the MDT application prototype at CLB to support the ABC MDT seemed to improve the quality of and confidence in clinical decisions. The integration of an MDT application with the local electronic medical record and the utilization of structured data conforming to international terminologies could enable a national network of MDTs to support sustained improvements to patient care.

Indexed as

advanced breast cancerbreast cancercancercareclinicianconfidencedatadigital healthelectronic medical recordsfollow-upgenomicmultidisciplinary meetingneoplasticpainpathologypatientrecordssoftwaretreatmenttumor

Identifiers

PMID37200077
PMCPMC10236276

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.